Description
Key Features
- For humidification of the upper and lower airways
- Natural isotonic saline solution with sodium chloride 0.9% w/v
- Sterile unit-dose vials for hygienic, convenient use
- Preservative-free formulation
- Compatible with jet, ultrasonic, and membrane nebulisers
- Single-use 2.5 ml vials - discard any unused portion after opening
Product Details
AuraNeb® Sodium Chloride Inhalation Solution 0.9% w/v is formulated to be compatible with human body fluid and to provide sufficient humidification of the respiratory mucosa. By helping to reduce the sensation of dryness in the airways, it supports comfortable nebuliser therapy for people who need airway humidification. When used according to the instructions, the leaflet states that the solution may be administered to infants, people of advanced years, and pregnant or nursing women.
The product is supplied as 20 sterile 2.5 ml vials. Each vial is intended for single use only and should be opened immediately before use. Use only with a suitable nebuliser and follow the nebuliser manufacturer’s instructions.
Directions for Use
- Hold the vial gently and twist off the top.
- Pour the solution into the nebuliser chamber.
- Use the nebuliser according to the nebuliser manufacturer’s instructions.
- Discard any unused portion immediately after use. For single use only.
Dosage: 2.5 ml to 5 ml up to 4 times daily, as required. Users should ask a pharmacist, doctor, or qualified healthcare professional if they need advice.
Safety, Warnings, and Precautions
- Follow the instructions for use
- Contains no preservatives; opened vials and expired vials must be disposed of safely and immediately.
- Keep out of reach of children. The product includes small parts that may pose a choking hazard.
- Do not re-sterilise.
- Do not use opened or damaged vials, or solution that is discoloured or cloudy.
- If you have a hypersensitive bronchial system, consult your doctor or pharmacist before use.
- Patients with a hypersensitive bronchial system, such as asthma, may experience shortness of breath due to temporary constriction of the bronchia. Discontinue treatment and speak to a doctor or pharmacist if this occurs.